As with last year’s Summit, the Fourth Annual One Mind Summit will have a single focus. We will highlight what can be accomplished to help patients when researchers adopt new models.
One Mind believes that key components to accelerating research in neuroscience are open science and collaboration, the benefits of which are widely recognized in fields ranging from genomics to infectious diseases to AIDS to cancer.
These principles are being adopted in neuroscience research and development as well, with One Mind working to accelerate those efforts by supporting mandatory data sharing, researchers working outside of their siloes, and better diagnostics and treatments reaching the patient quicker. To realize the full benefits of open science and collaboration in neuroscience, the dots must be connected from bench to bedside.
Some great advice we received at last year’s Summit was to “think big and start small.” One Mind has done exactly that by supporting open science research to find better diagnostics and treatments for traumatic brain injury (TBI) and post-traumatic stress (PTS). We want to show that our collaborative research model can deliver better outcomes for patients faster than traditional methods.
Our goal this year is to show the successes that are realized when the lessons of last year’s Summit are addressed. We will report on progress in the field of TBI and the collaborative models One Mind has helped establish, as well as the technological tools we are developing to enable collaboration that we believe will be broadly applicable in neuroscience. Leaders and researchers from other neuroscience disease areas will also be brought together to learn from one other, see how everyone benefits from team science enabled with new tools and supported by a public-private partnership, and further develop innovative and cost-effective methods of conducting research in an effort to more rapidly advance diagnostics, treatments, and better patient outcomes.
Each speaker panel will address a particular model of collaboration in action. For such a goal to be effective we must acknowledge the interests of all involved: patients, clinicians, researchers, regulators, industry innovators and others.
I ask you to accept our invitation and come prepared to participate and engage fully in the 2015 One Mind Summit.
Very Respectfully,
Peter Chiarelli
General, U.S. Army (Retired)
Chief Executive Officer, One Mind